Dr. M. V. ChandrakanthMedical OncologistMBBS, MD - Internal Medicine, DM - Medical Oncology, DNB - Medical OncologyCareClues18 years experience
Share your experienceShare Profile


  • Biopsy
  • Chemotherapy
  • Bone Marrow Transplant
  • Management of Solid Tumours
  • Gastro intestinal Malignancies
  • Genito-urinary Malignancies
  • Breast Cancer
  • Lung Cancer
  • Lymphoma
  • Multiple Myeloma
  • PET CT Scan
  • Electrophoresis
  • Bence Jones tests
  • MRI scan
  • Nuclear imaging
  • Blood Workup


  • Medical Oncologist

Awards and Recognitions

  • Original article on “Study of markers of atherosclerosis including insulin resistance in patients with chronic renal failure”, Journal of diabetes mellitus, May 2012.
  • Original article on “Outcomes of treatment of unresectable esophageal carcinoma treated with chemoradiotherapy and oral metronomic chemotherapy: An experience from a rural cancer center”, Eastern J Medical Sciences 2016
  • Review article on “Compliance to Therapy as a Prognostic Marker in Osteosarcoma: New Kid on the Block!”, Diagnostic Pathology: Open Access, 2016, 1:3
  • Non-high dose methotrexate containing regimen in osteogenic sarcoma
  • HRQOL in patients with locally advanced head and neck cancer on oral metronomic chemotherapy
  • Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy
  • Expectations and preferences for palliative chemotherapy in head and neck cancers patients
  • Ceritinib in anaplastic lymphoma kinase-positive nonsmall cell lung cancer among patients who were previously exposed to crizotinib: Experience from the Indian subcontinent
  • ROS1 rearranged nonsmall cell lung cancer and crizotinib: An Indian experience
  • Randomized controlled trial of oral TKI vs chemotherapy in patients with advanced lung cancer-quality of life evaluation in the third line setting
  • An audit of oncology patients attending emergency department
  • Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dose methotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'
  • Best poster presentation in SIOP and ASCO poster presentation
  • Letter to editor on “Nivolumab instills hope in advanced NSCLC with poor PS “, Indian Journal of cancer, 2017
  • Health-related quality of life in patients with metastatic, relapsed, or inoperable squamous cell carcinoma of the head and neck in India South Asian Journal of Cancer 2016
  • Blastic plasmacytoid dendritic cell neoplasm: A rare subtype of myeloid leukemia, Hematology /oncology and stem cell therapy 2014
  • Dengue fever as a cause of febrile neutropenia in adult acute lymphoblastic leukemia: A single center experience Hematology /oncology and stem cell therapy 2014


  • Narayana Superspeciality Hospital, Howrah, Consultant
  • Parkview Super Speciality Hospital, Consultant
  • Chandrakanth Clinic, Consultant
  • Tata Memorial Hospital, Mumbai, Specialist Registrar Medical Oncology
HB 36 –A / 4 -36 / A / 5/ 1, HB Block, Sector III, BidhannagarParkview Super Speciality Hospital
No schedules available.